MedPath

Sodiumhexametaphosphate Versus MTA as Pulp Capping Material for Immature Permanent Teeth

Not Applicable
Not yet recruiting
Conditions
Pulp Disease, Dental
Interventions
Other: Pulp capping
Other: MTA
Drug: Sodiumhexametaphosphate
Registration Number
NCT06170762
Lead Sponsor
Minia University
Brief Summary

Sodiumhexametaphosphate will be used as capping material for dental pulp of immature permanent teeth

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • healthy children
  • cooperative children
  • deep carious lesion
  • traumatic pulp exposure
  • immature permanent teeth
Exclusion Criteria
  • uncooperative children
  • children with systemic disorders
  • non vital immature permanent teeth

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SodiumhexametaphosphatePulp capping-
MTAMTA-
SodiumhexametaphosphateSodiumhexametaphosphate-
MTAPulp capping-
Primary Outcome Measures
NameTimeMethod
Clinical successOne year

Absence of pain, tenderness, mobility and swelling

Radiographic successOne year

Absence of periapical lesions, internal resorption an external resorption also evidence of continuous root growth

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath